+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

From
Pulmonary Embolism Global Market Report 2024 - Product Thumbnail Image

Pulmonary Embolism Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Preeclampsia Drugs Global Market Report 2024 - Product Thumbnail Image

Preeclampsia Drugs Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
CAR/TCR Therapies in Oncology: Analytical Tool - Product Thumbnail Image

CAR/TCR Therapies in Oncology: Analytical Tool

  • Report
  • October 2024
  • Global
From
From
From
Atopic Dermatitis Global Market Report 2024 - Product Thumbnail Image

Atopic Dermatitis Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Gene Editing Therapeutics Market - Product Thumbnail Image

Gene Editing Therapeutics Market

  • Report
  • August 2024
  • 111 Pages
  • Global
From
Oncology Pharmaceuticals Market - Product Thumbnail Image

Oncology Pharmaceuticals Market

  • Report
  • October 2024
  • 181 Pages
  • Global
From
From
Drug API Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Drug API Market - Forecasts from 2024 to 2029

  • Report
  • August 2024
  • 101 Pages
  • Global
From
Pediatric Medicines: Global Markets - Product Thumbnail Image

Pediatric Medicines: Global Markets

  • Report
  • November 2019
  • 169 Pages
  • Global
From
From
From
Condyloma - Pipeline Insight, 2024 - Product Thumbnail Image

Condyloma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator